A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Natarajan, Rama, Ph.D, F.A.H.A, F.A.S.N. Research Bookmark and Share

Rama Natarajan, Ph.D, F.A.H.A, F.A.S.N. Research

The major focus of our research is to determine the cellular and molecular mechanisms that play key roles in the development of diabetic vascular complications. We use genomic, transcriptomic and epigenomic approaches in cell culture, animal and clinical models to examine our hypothesis that accelerated vascular complications result from enhanced vascular and renal cell growth, and also monocyte activation due to altered expression of inflammatory cytokines, chemokines and lipids under diabetic conditions.
 
We are actively evaluating molecular mechanisms involved in the expression of pathological genes under diabetic conditions and in promoting metabolic memory. We have demonstrated the role of specific chromatin histone posttranslational modifications in the epigenetic regulation of inflammatory genes. We use epigenomic profiling approaches to map histone modifications, DNA methylation and binding of chromatin factors at diabetes-regulated genes with techniques such as Chromatin immunoprecipitation (ChIP) assays, ChIP-linked to microarrays, and ChIP-Sequencing. We have uncovered key epigenetic alterations under diabetic conditions in vitro, in vivo in diabetic mice, and in cells from diabetic patients, and shown relevance to the phenomenon of metabolic memory.
 
Another active area is the evaluation of specific microRNAs in regulating the expression of inflammatory and fibrotic genes under diabetic conditions. We are examining various mechanisms of microRNA regulation, performing expression profiling using RNA-sequencing, and studying how key microRNAs co-operate with each other in a circuit to amplify the effects of growth factors under diabetic conditions. To test the functional significance in the kidney, we are generating microRNA knockout mice and also evaluating novel modified inhibitors of specific microRNAs (antagomirs) on the progression of diabetic kidney disease in mouse models.
 

Rama Natarajan, Ph.D., Lab Members

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rama Natarajan, Ph.D., F.A.H.A, F.A.S.N.
National Office Products Endowed Professor
626-256-HOPE (4673), ext. 62289
 
Marpadga A. Reddy, Ph.D.
Assistant Research Professor
626-256-HOPE (4673), ext. 63671
 
Feng Miao, Ph.D.
Assistant Research Professor
626-256-HOPE (4673), ext. 65575
 
Mitsuo Kato, Ph.D.
Assistant Research Professor
626-256-HOPE (4673), ext. 63996
 
Kirti Bhatt, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 65811
 
Nancy Castro, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 64690
 
Ye Jia, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 62289
 
Amy Leung, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 62278
 
Jung-tak Park, M.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 64809
 
Hang Yuan, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 65817
 
Supriya Deschpande
Graduate Student
626-256-HOPE (4673), ext. 65835
 
Wen Jin
Graduate Student
626-256-HOPE (4673), ext. 65823
 
Linda Lanting, B.S.
Research Associate
626-256-HOPE (4673), ext. 64692
 
Mei Wang, M.S.
Research Associate
626-256-HOPE (4673), ext. 64676
 
Lingxiao Zhang, M.S.
Research Associate
626-256-HOPE (4673), ext. 65571
 
Nancy (Zhuo) Chen
Bioinformatics Specialist
656-256-HOPE (4673), ext. 65058
 

Natarajan, Rama, Ph.D, F.A.H.A, F.A.S.N. Research

Rama Natarajan, Ph.D, F.A.H.A, F.A.S.N. Research

The major focus of our research is to determine the cellular and molecular mechanisms that play key roles in the development of diabetic vascular complications. We use genomic, transcriptomic and epigenomic approaches in cell culture, animal and clinical models to examine our hypothesis that accelerated vascular complications result from enhanced vascular and renal cell growth, and also monocyte activation due to altered expression of inflammatory cytokines, chemokines and lipids under diabetic conditions.
 
We are actively evaluating molecular mechanisms involved in the expression of pathological genes under diabetic conditions and in promoting metabolic memory. We have demonstrated the role of specific chromatin histone posttranslational modifications in the epigenetic regulation of inflammatory genes. We use epigenomic profiling approaches to map histone modifications, DNA methylation and binding of chromatin factors at diabetes-regulated genes with techniques such as Chromatin immunoprecipitation (ChIP) assays, ChIP-linked to microarrays, and ChIP-Sequencing. We have uncovered key epigenetic alterations under diabetic conditions in vitro, in vivo in diabetic mice, and in cells from diabetic patients, and shown relevance to the phenomenon of metabolic memory.
 
Another active area is the evaluation of specific microRNAs in regulating the expression of inflammatory and fibrotic genes under diabetic conditions. We are examining various mechanisms of microRNA regulation, performing expression profiling using RNA-sequencing, and studying how key microRNAs co-operate with each other in a circuit to amplify the effects of growth factors under diabetic conditions. To test the functional significance in the kidney, we are generating microRNA knockout mice and also evaluating novel modified inhibitors of specific microRNAs (antagomirs) on the progression of diabetic kidney disease in mouse models.
 

Lab Members

Rama Natarajan, Ph.D., Lab Members

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rama Natarajan, Ph.D., F.A.H.A, F.A.S.N.
National Office Products Endowed Professor
626-256-HOPE (4673), ext. 62289
 
Marpadga A. Reddy, Ph.D.
Assistant Research Professor
626-256-HOPE (4673), ext. 63671
 
Feng Miao, Ph.D.
Assistant Research Professor
626-256-HOPE (4673), ext. 65575
 
Mitsuo Kato, Ph.D.
Assistant Research Professor
626-256-HOPE (4673), ext. 63996
 
Kirti Bhatt, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 65811
 
Nancy Castro, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 64690
 
Ye Jia, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 62289
 
Amy Leung, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 62278
 
Jung-tak Park, M.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 64809
 
Hang Yuan, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 65817
 
Supriya Deschpande
Graduate Student
626-256-HOPE (4673), ext. 65835
 
Wen Jin
Graduate Student
626-256-HOPE (4673), ext. 65823
 
Linda Lanting, B.S.
Research Associate
626-256-HOPE (4673), ext. 64692
 
Mei Wang, M.S.
Research Associate
626-256-HOPE (4673), ext. 64676
 
Lingxiao Zhang, M.S.
Research Associate
626-256-HOPE (4673), ext. 65571
 
Nancy (Zhuo) Chen
Bioinformatics Specialist
656-256-HOPE (4673), ext. 65058
 
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • No one ever plans to have cancer – and there’s never a good time. For Homa Sadat, her cancer came at a particularly bad time: just one year after losing her father to the pancreatic cancer he had battled for two years. She was working a grueling schedule managing three commercial office buildings. She’d just [&...
  • Patients at City of Hope – most of whom are fighting cancer – rely on more than 37,000 units of blood and platelets each year for their treatment and survival. Every one of those units comes from family, friends or someone who traded an hour or so of their time and a pint of their […]
  • Surgery is vital in the treatment of cancer – it’s used to help diagnose, treat and even prevent the disease – so a new colorectal cancer study linking a decrease in surgeries for advanced cancer to increased survival rates may raise more questions than it answers for some patients. The surgery-and-surviv...
  • Age is the single greatest risk factor overall for cancer; our chances of developing the disease rise steeply after age 50. For geriatric oncology nurse Peggy Burhenn, the meaning is clear: Cancer is primarily a geriatric condition. That’s why she is forging inroads in the care of older adults with cancer. Burh...
  • One of American’s great sportscasters, Stuart Scott, passed away from recurrent cancer of the appendix at the young age of 49. His cancer was diagnosed when he was only 40 years old. It was found during an operation for appendicitis. His courageous fight against this disease began in 2007, resumed again with an...
  • When Homa Sadat found a lump in her breast at age 27, her gynecologist told her what many doctors say to young women: You’re too young to have breast cancer. With the lump dismissed as a harmless cyst, she didn’t think about it again until she was at a restaurant six months later and felt […]
  • What most people call a “bone marrow transplant” is not actually a transplant of bone marrow; it is instead the transplantation of what’s known as hematopoietic stem cells. Such cells are often taken from bone marrow, but not always. Hematopoietic stem cells are simply immature cells that can ...
  • Doctors have long known that women with a precancerous condition called atypical hyperplasia have an elevated risk of breast cancer. Now a new study has found that the risk is more serious than previously thought. Hyperplasia itself is an overgrowth of cells; atypical hyperplasia is an overgrowth in a distorted...
  • Don’t kid yourself. Just because it’s mid-January doesn’t mean it’s too late to make resolutions for a happier, and healthier, 2015. Just consider them resolutions that are more mature than those giddy, sometimes self-deluded, Jan. 1 resolutions. To that end, we share some advice from Cary A. Presant, M.D., an ...
  • Sales and marketing executive Jim Murphy first came to City of Hope in 2002 to donate blood for a friend who was being treated for esophageal cancer. The disease is serious. Although esophageal cancer accounts for only about 1 percent of cancer diagnoses in the U.S., only about 20 percent of patients survive at...
  • Aaron Bomar and his family were celebrating his daughter’s 33rd birthday in September 2014 when he received alarming news: According to an X-ray taken earlier that day at an urgent care facility, he had a node on his aorta and was in danger of an aneurysm. Bomar held hands with his wife and daughter and s...
  • Explaining a prostate cancer diagnosis to a young child can be difficult — especially when the cancer is incurable. But conveying the need for prostate cancer research, as it turns out, is easily done. And that leads to action. Earlier this year, Gerald Rustad, 71, who is living with a very aggressive form of m...
  • Cancer and its treatment can create unexpected daily challenges for patients. Side effects from chemotherapy, surgery and radiation therapy as well as the disease itself can cause difficulty in everything from speech to movement to eating. When this happens, rehabilitation is vital; it helps patients restore th...
  • Betsy Sauer and her four daughters share plenty in common. They’re smart and successful.  They’re funny, ranging from wryly witty to wickedly hilarious. Their hobbies tend toward the active and adventurous: hiking, rock climbing, skiing, swimming, fishing, kayaking, yoga and horseback riding. Also, they take he...
  • Flu season is upon us, and few people should take the risk of infection more seriously than cancer patients and their loved ones and caregivers. With the federal Centers for Disease Control and Prevention warning of widespread influenza outbreaks, it’s clear that flu season – and the associated risks – won’t en...